Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: Anti-Toxoplasma immune response in mice

Abstract

A multicomponent DNA vaccine, encoding Toxoplasma gondii GRA1 and SAG1, was constructed and tested for its ability to confer protection. BALB/c mice were challenged with tachyzoites of the virulent T. gondii RH strain at 4 weeks following the last immunization, and immune responses and survival times were observed. The results show that vaccination by the multicomponent vaccine prolonged survival of mice challenged with the T. gondii RH strain (from average 4.50∈±∈0.22 to 7.60∈±∈0.74 days); induced high levels of IgG antibody (from 0.252∈±∈0.080 to 0.790∈±∈0.083), IFN-gamma (from 598.74∈±∈67.50 to 853.77∈±∈66.74 pg/ml), and IL-2 (from 89. 44∈±∈10.66 to 192.24∈±∈19.90 pg/ml); changed the CD4+/CD8+ lymphocyte ratio (from 1. 81∈±∈0.14 to 1.09∈±∈0.19); and stimulated NK cell-killing activity (from 46.81∈±∈3.96 to 64.15∈±∈7.71 %). These findings demonstrate that a multicomponent DNA vaccine, encoding GRA1 and SAG1, primes a strong humoral and cellular immune response and enhances protection against T. gondii challenge. The new, combined DNA vaccine provides another means to combat T. gondii infection. © 2012 The Author(s).